Marcela Maus

Marcela Maus leads the Cellular Immunotherapy Program at Massachusetts General Hospital, focused on next-generation CAR-T manufacturing and solid tumor applications. She has developed CAR-T targeting mesothelin and EGFRvIII for solid tumors and explored strategies to streamline manufacturing toward point-of-care production. Her lab addresses key barriers including T cell product quality and tumor microenvironment penetration.